Xinyi Wang Selected Research

Colorectal Neoplasms (Colorectal Cancer)

1/2022	Erratum: Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis: Erratum.
1/2022	lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin.
1/2021	Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer.
1/2020	Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
1/2020	Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinyi Wang Research Topics

Disease

66	Neoplasms (Cancer) 08/2022 - 11/2011
12	Neoplasm Metastasis (Metastasis) 08/2022 - 02/2016
12	Carcinogenesis 11/2020 - 07/2014
11	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2015
11	Wounds and Injuries (Trauma) 01/2022 - 11/2011
11	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2016
10	Inflammation (Inflammations) 07/2022 - 01/2017
9	Infections 01/2022 - 12/2014
8	COVID-19 01/2022 - 01/2020
7	Cicatrix (Scar) 01/2022 - 01/2009
6	Hypothyroidism 04/2022 - 08/2015
6	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2016
6	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 12/2015 - 01/2009
5	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2019
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
5	Hypoxia (Hypoxemia) 01/2022 - 01/2019
5	Fibrosis (Cirrhosis) 11/2021 - 01/2017
5	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2014
4	Body Weight (Weight, Body) 12/2021 - 01/2018
4	Malaria 01/2021 - 01/2020
4	Cognitive Dysfunction 01/2020 - 01/2015
4	Thyroid Diseases (Thyroid Disease) 06/2018 - 01/2016
3	Carcinoma (Carcinomatosis) 06/2022 - 01/2017
3	Dementia (Dementias) 01/2022 - 01/2020
3	Ischemia 01/2022 - 01/2020
3	Ischemic Stroke 01/2022 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 05/2017
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 11/2020
3	Autoimmune Diseases (Autoimmune Disease) 08/2019 - 01/2017
2	Leukemia 06/2022 - 01/2022
2	Bacterial Infections (Bacterial Infection) 05/2022 - 01/2022
2	Communicable Diseases (Infectious Diseases) 05/2022 - 01/2021
2	Urolithiasis 01/2022 - 01/2020
2	Pathologic Constriction (Stenosis) 01/2022 - 01/2021
2	Brain Injuries (Brain Injury) 01/2022 - 08/2016
2	Pain (Aches) 01/2022 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 01/2019
2	Heart Failure 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2013
2	Postoperative Pain 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 11/2021 - 01/2017
2	Zika Virus Infection 11/2021 - 10/2019
2	Pneumonia (Pneumonitis) 02/2021 - 01/2020
2	Hyperglycemia 01/2021 - 11/2011

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2013
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
11	Pharmaceutical PreparationsIBA 08/2022 - 02/2017
9	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2018
9	CytokinesIBA 01/2022 - 01/2017
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 02/2013
7	VaccinesIBA 01/2022 - 08/2018
7	Biological ProductsIBA 01/2022 - 05/2017
7	MicroRNAs (MicroRNA)IBA 03/2020 - 01/2015
7	Collagen Type VIIIBA 12/2015 - 06/2007
6	Messenger RNA (mRNA)IBA 06/2022 - 04/2017
6	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2017
6	Circular RNAIBA 01/2022 - 01/2019
6	EnzymesIBA 10/2021 - 06/2007
6	LigandsIBA 01/2021 - 01/2016
5	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2017
5	CollagenIBA 10/2021 - 06/2007
4	PlatinumIBA 01/2022 - 01/2019
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2022 - 08/2016
3	Etoposide (VP 16)FDA LinkGeneric 06/2022 - 11/2016
3	ProteomeIBA 06/2022 - 01/2019
3	Protein Isoforms (Isoforms)IBA 06/2022 - 01/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 11/2011
3	ProdrugsIBA 01/2022 - 01/2019
3	Therapeutic UsesIBA 01/2022 - 01/2020
3	Tapentadol FDA Link 01/2022 - 01/2020
3	Long Noncoding RNAIBA 01/2022 - 08/2019
3	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022 - 01/2020
3	AntibodiesIBA 11/2021 - 04/2014
3	DN604IBA 01/2021 - 01/2019
3	CateninsIBA 01/2021 - 01/2018
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2016
3	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 11/2019 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 07/2017 - 01/2016
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 07/2014
3	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 07/2014
2	Serotonin (5 Hydroxytryptamine)IBA 10/2022 - 01/2016
2	SodiumIBA 01/2022 - 10/2019
2	SphingolipidsIBA 01/2022 - 01/2019
2	IronIBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2021
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2021
2	AntioxidantsIBA 12/2021 - 09/2018
2	KynurenineIBA 02/2021 - 01/2021
2	Antimalarials (Antimalarial Agents)IBA 01/2021 - 01/2021
2	CreatinineIBA 01/2021 - 12/2020
2	Gemcitabine FDA Link 01/2021 - 11/2020

Therapy/Procedure

41	Therapeutics 08/2022 - 11/2011
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2020
3	Immunotherapy 02/2021 - 10/2020
2	Photothermal Therapy 01/2022 - 10/2021
2	Ambulatory Care (Outpatient Care) 01/2022 - 12/2014